Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Research Communications in Molecular Pathology and Pharmacology

• Publication date

  1997-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 9507565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture.

  1995cited by this paper
• Serum hepatocyte growth factor levels in liver diseases: Clinical implications

  1995cited by this paper
• Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis.

  1994cited by this paper
• Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis.

  1994cited by this paper
• Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration.

  1994cited by this paper
• Ultrastructural location of human hepatocyte growth factor in human liver

  1994cited by this paper
• Expression of hepatocyte growth factor in normal and carbon tetrachloride–treated monkeys

  1994cited by this paper
• Fibroblast growth factors modulate intestinal epithelial cell growth and migration.

  1994cited by this paper
• Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells.

  1994cited by this paper
• Hepatocyte growth factor induces mitogenic reaction to the rabbit gastric epithelial cells in primary culture.

  1993cited by this paper
• Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride–intoxicated rats

  1993cited by this paper
• Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts.

  1992cited by this paper
• Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells.

  1992cited by this paper
• Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine.

  1992cited by this paper
• Significance of serum human hepatocyte growth factor levels in patients with hepatic failure

  1992cited by this paper
• Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors.

  1991cited by this paper
• Evidence for the identity of human scatter factor and human hepatocyte growth factor.

  1991cited by this paper
• Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme‐linked immunosorbent assay

  1991cited by this paper
• Expression of the Met/HGF receptor in normal and neoplastic human tissues.

  1991cited by this paper
• Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor.

  1990cited by this paper
• Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes.

  1990cited by this paper
• Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins.

  1989cited by this paper
• Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells.

  1989cited by this paper
• Characterization of the mouse met proto-oncogene.

  1988cited by this paper
• Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.

  1988cited by this paper
• Purification and subunit structure of hepatocyte growth factor from rat platelets

  1987cited by this paper
• Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation.

  1987cited by this paper
• Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.

  1984cited by this paper

• Association of Serum Hepatocyte Growth Factor Level with Systemic Inflammatory Biomarkers in Patients with Pancreatobiliary Cancer

  2023cites this paper
• Experimental and clinical evidence of endothelial dysfunction in inflammatory bowel disease.

  2020cites this paper
• The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury

  2016cites this paper
• Panel de biomarqueurs pour l'évaluation de la cicatrisation muqueuse

  2015cites this paper
• Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice

  2014cites this paper
• Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow

  2007cites this paper
• Role of angiogenesis in inflammatory bowel disease

  2006influential citation
• Multianalyte profiling of serum cytokines for detection of pancreatic cancer

  2005cites this paper
• High Hepatocyte Growth Factor Levels in Faeces During Acute Infectious Gastroenteritis

  2003cites this paper
• Hepatocyte growth factor: from diagnosis to clinical applications.

  2003cites this paper
• Remission, relapse, intestinal healing and repair

  2003cites this paper
• Possible involvement of neutrophil elastase in impaired mucosal repair in patients with ulcerative colitis

  2002cites this paper
• Growth Factors in Development and Diseases of the Exocrine Pancreas

  2001cites this paper
• Ulcerative Proctitis, Rectal Prolapse, and Intestinal Pseudo-Obstruction in Transgenic Mice Overexpressing Hepatocyte Growth Factor/Scatter Factor

  2001cites this paper
• Transforming growth factor‐beta and hepatocyte growth factor plasma levels in patients with inflammatroy bowel disease

  2000cites this paper